What Researchers Did
Researchers investigated the prevalence of carbon monoxide (CO) poisoning and the provision of hyperbaric oxygen therapy (HBOT) in South Korea using national claims data from 2010 to 2019.
What They Found
A total of 44,361 patients with CO poisoning were identified over 10 years, showing a prevalence of 8.64/10,000 people with a gradual annual increase. The highest prevalence was 11.01/10,000 individuals among those aged 30-39 years. HBOT claims increased from 15 hospitals in 2010 to 30 in 2019, with 4,473 patients receiving HBOT, and 2,684 (60%) treated for more than 2 hours.
What This Means for Canadian Patients
This study's findings are specific to South Korea and do not directly impact Canadian patients. However, understanding trends in CO poisoning and HBOT utilization in other developed nations can offer insights for Canadian public health planning and emergency response strategies.
Canadian Relevance
There is no direct Canadian connection to this study, as it exclusively analyzed South Korean national claims data.
Study Limitations
The study's reliance on national claims data may not capture all cases of CO poisoning or HBOT, and observed regional disparities were not fully explored.